Review
Sep 2026
Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysis.
BACKGROUND Autologous hematopoietic stem cell transplantation (AHSCT) and alemtuzumab are high-efficacy immune reconstitution therapies for highly active multiple sclerosis (MS), but direct comparative evidence remains limited. OBJECTIVE To compare the efficacy and safety of AHSCT versus alemtuzumab in patients with...
Naima Kebir, Salem Waleed, Yousef El Sayed et al.
· Multiple Sclerosis and Relat... · 0 citations